<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8621390" created="10/07/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8621390</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="transcriptional_regulation" sem="Other">Transcriptional regulation</term> of the <term id="T2" lex="interleukin-2_gene" sem="DNA_domain_or_region"><term id="T3" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> gene</term> in normal <term id="T4" lex="human_peripheral_blood_T_cell" sem="Cell_natural">human peripheral blood T cells</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Regulation"/>
<theme idref="T2"/>
<clue>Transcriptional regulation <linkTheme>of</linkTheme> the interleukin-2 gene <clueLoc>in normal human peripheral blood T cells.</clueLoc></clue>
</event>
<sentence id="S2">Convergence of costimulatory signals and differences from <term id="T5" lex="transformed_T_cell" sem="Cell_natural">transformed T cells</term>.</sentence>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">To study transcriptional regulation in <term id="T6" lex="normal_human_T_cell" sem="Cell_natural">normal human T cells</term>, we have optimized conditions for <term id="T7" lex="transient_transfection" sem="Other">transient transfection</term>.</sentence>
<sentence id="S4"><term id="T8" lex="interleukin-2_(IL-2)_promoter" sem="DNA_domain_or_region">Interleukin-2 (<term id="T9" lex="IL-2" sem="Protein_molecule">IL-2</term>) promoter</term><term id="T10" lex="reporter_gene" sem="DNA_family_or_group">-reporter gene</term> behavior closely parallels the <term id="T11" lex="endogenous_gene" sem="DNA_family_or_group">endogenous gene</term> in response to <term id="T12" lex="T_cell_receptor" sem="Protein_molecule">T cell receptor</term> and <term id="T13" lex="costimulatory_signal" sem="Other">costimulatory signals</term>.</sentence>
<event KT="Other" id="E2">
<type class="Regulation"/>
<theme idref="T10"/>
<cause idref="T12"/>
<clue>Interleukin-2 (IL-2) promoter-reporter gene behavior closely parallels the endogenous gene in <clueType>response</clueType> <linkCause>to</linkCause> T cell receptor and costimulatory signals.</clue>
</event>
<event KT="Other" id="E3">
<type class="Regulation"/>
<theme idref="T10"/>
<cause idref="T13"/>
<clue>Interleukin-2 (IL-2) promoter-reporter gene behavior closely parallels the endogenous gene in <clueType>response</clueType> <linkCause>to</linkCause> T cell receptor and costimulatory signals.</clue>
</event>
<event KT="Other" id="E4">
<type class="Regulation"/>
<theme idref="T11"/>
<cause idref="T12"/>
<clue>Interleukin-2 (IL-2) promoter-reporter gene behavior closely parallels the endogenous gene in <clueType>response</clueType> <linkCause>to</linkCause> T cell receptor and costimulatory signals.</clue>
</event>
<event KT="Other" id="E5">
<type class="Regulation"/>
<theme idref="T11"/>
<cause idref="T13"/>
<clue>Interleukin-2 (IL-2) promoter-reporter gene behavior closely parallels the endogenous gene in <clueType>response</clueType> <linkCause>to</linkCause> T cell receptor and costimulatory signals.</clue>
</event>
<sentence id="S5">As assessed with <term id="T14" lex="mutagenized_promoter" sem="DNA_family_or_group">mutagenized promoters</term>, the most important <term id="T15" lex="IL-2_cis-regulatory_element" sem="DNA_domain_or_region"><term id="T16" lex="IL-2" sem="Protein_molecule">IL-2</term> cis-regulatory elements</term> in <term id="T17" lex="normal_T_cell" sem="Cell_natural">normal T cells</term> are the <term id="T18" lex="proximal_AP-1_site" sem="DNA_domain_or_region">proximal <term id="T19" lex="AP-1" sem="Protein_molecule">AP-1</term> site</term> and the <term id="T20" lex="NF-_kappaB_site" sem="DNA_domain_or_region"><term id="T21" lex="NF-_kappaB" sem="Protein_molecule">NF- kappaB</term> site</term>.</sentence>
<sentence id="S6">Both primary activation, with <term id="T22" lex="phytohemagglutinin" sem="Protein_molecule">phytohemagglutinin</term> or <term id="T23" lex="antibody_to_CD3" sem="Protein_family_or_group">antibodies to CD3</term>, and <term id="T24" lex="costimulation" sem="Other">costimulation</term>, provided by pairs of <term id="T25" lex="CD2_antibody" sem="Protein_family_or_group">CD2 antibodies</term> or <term id="T26" lex="B7-positive_(B_cells)" sem="Cell_natural">B7-positive (B cells)</term> or <term id="T27" lex="B7-negative_(endothelial)_accessory_cell" sem="Cell_natural">B7-negative (endothelial) accessory cells,</term> are mediated through the same <term id="T28" lex="cis-element" sem="DNA_family_or_group">cis-elements</term>.</sentence>
<event id="E6">
<type class="Positive_regulation"/>
<cause idref="T22"/>
<clue>Both primary activation, <linkCause>with</linkCause> phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are mediated through the same cis-elements.</clue>
</event>
<event id="E7">
<type class="Positive_regulation"/>
<cause idref="T23"/>
<clue>Both primary activation, <linkCause>with</linkCause> phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are mediated through the same cis-elements.</clue>
</event>
<event id="E8">
<type class="Positive_regulation"/>
<cause idref="T25"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and <clueType>costimulation</clueType>, provided <linkCause>by</linkCause> pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are mediated through the same cis-elements.</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<cause idref="T26"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and <clueType>costimulation</clueType>, provided <linkCause>by</linkCause> pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are mediated through the same cis-elements.</clue>
</event>
<event id="E10">
<type class="Positive_regulation"/>
<cause idref="T27"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and <clueType>costimulation</clueType>, provided <linkCause>by</linkCause> pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are mediated through the same cis-elements.</clue>
</event>
<event id="E11">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T18"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T18"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T18"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E14">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T18"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T18"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<cause idref="T20"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E17">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="T20"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T20"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E19">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<cause idref="T20"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<event id="E20">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<cause idref="T20"/>
<clue>Both primary activation, with phytohemagglutinin or antibodies to CD3, and costimulation, provided by pairs of CD2 antibodies or B7-positive (B cells) or B7-negative (endothelial) accessory cells, are <clueType>mediated</clueType> <linkCause>through</linkCause> <corefCause>the same cis-elements</corefCause>.</clue>
</event>
<sentence id="S7">Interestingly, the <term id="T29" lex="nuclear_factor_of_activated_T_cells_site" sem="DNA_domain_or_region">nuclear factor of activated T cell sites</term> are much less important in <term id="T30" lex="normal_T_cell" sem="Cell_natural">normal T cells</term> than in <term id="T31" lex="Jurkat_T_cell" sem="Cell_cultured">Jurkat T cells</term>.</sentence>
<sentence id="S8">We conclude that <term id="T32" lex="IL-2" sem="Protein_molecule">IL-2</term> transcriptional regulation differs in <term id="T33" lex="tumor_cell_line" sem="Cell_cultured">tumor cell lines</term> compared with <term id="T34" lex="normal_T_cell" sem="Cell_natural">normal T cells</term> and that different <term id="T35" lex="costimulatory_signal" sem="Other">costimulatory signals</term> converge on the same <term id="T36" lex="cis-element" sem="DNA_family_or_group">cis-elements</term> in the <term id="T37" lex="IL-2_promoter" sem="DNA_domain_or_region"><term id="T38" lex="IL-2" sem="Protein_molecule">IL-2</term> promoter</term>.</sentence>
<event KT="Analysis" id="E21">
<type class="Regulation"/>
<theme idref="T32"/>
<clue>We <clueKT>conclude</clueKT> that IL-2 <clueType>transcriptional regulation</clueType> differs <clueLoc>in tumor cell lines</clueLoc> compared with normal T cells and that different costimulatory signals converge on the same cis-elements in the IL-2 promoter.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Regulation"/>
<theme idref="T32"/>
<clue>We <clueKT>conclude</clueKT> that IL-2 <clueType>transcriptional regulation</clueType> differs <clueLoc>in</clueLoc> tumor cell lines compared with <clueLoc>normal T cells</clueLoc> and that different costimulatory signals converge on the same cis-elements in the IL-2 promoter.</clue>
</event>
<event KT="Analysis" id="E23">
<type class="Binding"/>
<theme idref="T35"/>
<theme idref="T18"/>
<clue>We <clueKT>conclude</clueKT> that IL-2 transcriptional regulation differs in tumor cell lines compared with normal T cells and that different costimulatory signals <clueType>converge</clueType> <linkTheme>on</linkTheme> the <corefTheme idref1="T18">same cis-elements</corefTheme> in the IL-2 promoter.</clue>
</event>
<event KT="Analysis" id="E24">
<type class="Binding"/>
<theme idref="T35"/>
<theme idref="T20"/>
<clue>We <clueKT>conclude</clueKT> that IL-2 transcriptional regulation differs in tumor cell lines compared with normal T cells and that different costimulatory signals <clueType>converge</clueType> <linkTheme>on</linkTheme> the <corefTheme idref1="T20">same cis-elements</corefTheme> in the IL-2 promoter.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
